Press Releases Say AI Is Saving Medicine. Bluesky Says It's Already Denying Your Claims.

There are two healthcare AI stories running simultaneously right now, and they are not in dialogue with each other. In one story, deep learning is improving physician accuracy on chest X-rays, explainable AI is building patient trust in melanoma diagnosis, and the AI-in-medicine market is growing at a rate that would make any investor's eyes widen. In the other story, insurance companies have cut out the human factor entirely by having AI make claim denials, AI-generated emergency alerts in Baltimore are flagging their own unreliability, and someone on Bluesky is lying awake at night thinking about Medicare recipients losing access to procedures they've already been approved for.

The news ecosystem covering healthcare AI is publishing almost exclusively from the first story. Research papers out of Nature are optimistic and methodologically careful. Market reports are bullish. The tone is that of a technology arriving to help doctors do their jobs better. Bluesky, meanwhile, is running the second story almost exclusively — and the sharpest posts there aren't from people who distrust technology in the abstract. They're from people describing specific mechanisms: insurers use AI to generate denials at scale, removing the deliberation that occasionally let appeals succeed. That's not a fear of the future. That's a description of something already operational.

What makes the gap so wide isn't that one side is misinformed. The research on AI-assisted radiology is real. The claim-denial automation is also real. They just describe entirely different parts of a system that gets called by the same name. When journalists write about